Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
002219.SZ Stock Summary
Top 10 Correlated ETFs
002219.SZ
In the News
002219.SZ Financial details
Company Rating
Strong Buy
Market Cap
12.01B
Income
162.25M
Revenue
3.24B
Book val./share
0.63
Cash/share
0.18
Dividend
-
Dividend %
-
Employees
7.82K
Optionable
No
Shortable
Yes
Earnings
29 Apr 2022
P/E
71.61
Forward P/E
-
PEG
-5.48
P/S
3.62
P/B
5.55
P/C
19.33
P/FCF
565.09
Quick Ratio
0.62
Current Ratio
0.7
Debt / Equity
0.78
LT Debt / Equity
0.36
-
-
EPS (TTM)
0.06
EPS next Y
-
EPS next Q
-
EPS this Y
-123.85%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-3.86%
Revenue Q/Q
6.47%
EPS Q/Q
63.08%
-
-
-
-
SMA20
-0.28%
SMA50
-18.1%
SMA100
-26.61%
Inst Own
-
Inst Trans
-
ROA
3%
ROE
9%
ROC
0.05%
Gross Margin
33%
Oper. Margin
4%
Profit Margin
5%
Payout
163%
Shs Outstand
3.38B
Shs Float
1.69B
-
-
-
-
Target Price
-
52W Range
3.41-5.88
52W High
-30.4%
52W Low
+16%
RSI
42.26
Rel Volume
0.86
Avg Volume
17.39M
Volume
14.99M
Perf Week
-2.79%
Perf Month
-8.42%
Perf Quarter
-30.26%
Perf Half Y
-30.82%
-
-
-
-
Beta
0.316821
-
-
Volatility
0.04%, 0.07%
Prev Close
-1.42%
Price
3.48
Change
1.46%
002219.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 2.06 | 1.97 | 1.5 | 1.62 | 0.97 | |
Net income per share | -0.76 | -1.34 | -0.02 | -0.2 | 0.05 | |
Operating cash flow per share | 0.28 | 0.29 | 0.15 | 0.15 | 0.08 | |
Free cash flow per share | 0.16 | 0.18 | 0.04 | 0.04 | 0.01 | |
Cash per share | 0.15 | 0.04 | 0.06 | 1.05 | 0.17 | |
Book value per share | 1.45 | 0.1 | 0.07 | 0.83 | 0.53 | |
Tangible book value per share | -0.43 | -0.58 | -0.59 | 0.23 | 0.19 | |
Share holders equity per share | 1.45 | 0.1 | 0.07 | 0.83 | 0.53 | |
Interest debt per share | 1.86 | 1.71 | 1.37 | 1.43 | 0.53 | |
Market cap | 6.42B | 4.46B | 3.3B | 6.83B | 12.85B | |
Enterprise value | 9.2B | 7.19B | 5.56B | 7.23B | 13.88B | |
P/E ratio | -4.53 | -1.79 | -77.68 | -18.59 | 82.6 | |
Price to sales ratio | 1.67 | 1.21 | 1.18 | 2.26 | 4.08 | |
POCF ratio | 12.28 | 8.12 | 11.64 | 24.62 | 47.96 | |
PFCF ratio | 21.24 | 13.36 | 49.13 | 86.91 | 276.64 | |
P/B Ratio | 2.37 | 22.9 | 24.67 | 4.4 | 7.46 | |
PTB ratio | 2.37 | 22.9 | 24.67 | 4.4 | 7.46 | |
EV to sales | 2.4 | 1.95 | 1.98 | 2.4 | 4.4 | |
Enterprise value over EBITDA | 238.77 | -31.95 | 15.07 | 22.8 | 26.46 | |
EV to operating cash flow | 17.61 | 13.08 | 19.58 | 26.09 | 51.78 | |
EV to free cash flow | 30.46 | 21.53 | 82.66 | 92.07 | 298.7 | |
Earnings yield | -0.22 | -0.56 | -0.01 | -0.05 | 0.01 | |
Free cash flow yield | 0.05 | 0.07 | 0.02 | 0.01 | 0 | |
Debt to equity | 1.16 | 14.63 | 18.13 | 1.57 | 0.92 | |
Debt to assets | 0.36 | 0.58 | 0.5 | 0.36 | 0.28 | |
Net debt to EBITDA | 72.28 | -12.12 | 6.11 | 1.28 | 1.95 | |
Current ratio | 0.77 | 0.27 | 0.29 | 0.66 | 0.54 | |
Interest coverage | -3.77 | 0.35 | 1.45 | 0.67 | 2.51 | |
Income quality | -0.38 | -0.22 | -6.68 | -0.75 | 1.63 | |
Dividend Yield | 0.05 | 0.09 | 0.03 | 0.01 | 0.02 | |
Payout ratio | -0.23 | -0.16 | -1.97 | -0.15 | 1.77 | |
Sales general and administrative to revenue | 0.04 | 0.06 | 0.03 | 0.04 | 0.03 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.42 | 0.26 | 0.26 | 0.17 | 0.2 | |
Capex to operating cash flow | -0.42 | -0.39 | -0.76 | -0.72 | -0.83 | |
Capex to revenue | -0.06 | -0.06 | -0.08 | -0.07 | -0.07 | |
Capex to depreciation | -0.96 | -1.6 | -1.27 | -1.22 | -1.33 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 4.99 | 1.77 | 0.19 | 1.92 | 0.75 | |
ROIC | -0.23 | 0.04 | -0.33 | 0.04 | 0.09 | |
Return on tangible assets | -0.28 | -0.69 | -0.01 | -0.07 | 0.03 | |
Graham Net | -2.28 | -2.09 | -2.05 | -1.32 | -0.75 | |
Working capital | -667.83M | -3.04B | -2.89B | -1.53B | -1.53B | |
Tangible asset value | -801.92M | -1.08B | -1.1B | 427.92M | 615.68M | |
Net current asset value | -3.6B | -3.56B | -3.46B | -2.08B | -2.08B | |
Invested capital | 1.16 | 14.63 | 18.13 | 1.57 | 0.92 | |
Average receivables | 1.8B | 1.24B | 850.26M | 811.47M | 920.17M | |
Average payables | 606.2M | 729.79M | 852.98M | 937.6M | 1.08B | |
Average inventory | 576.89M | 231.62M | 166.54M | 181.77M | 174.85M | |
Days sales outstanding | 154.5 | 85.37 | 109.1 | 94.91 | 122.27 | |
Days payables outstanding | 76.16 | 111.87 | 158.45 | 165.35 | 196.22 | |
Days of inventory on hand | 37.38 | 20.83 | 32.29 | 30.62 | 27.78 | |
Receivables turnover | 2.36 | 4.28 | 3.35 | 3.85 | 2.99 | |
Payables turnover | 4.79 | 3.26 | 2.3 | 2.21 | 1.86 | |
Inventory turnover | 9.76 | 17.52 | 11.3 | 11.92 | 13.14 | |
ROE | -0.52 | -12.82 | -0.32 | -0.24 | 0.09 | |
Capex per share | -0.12 | -0.12 | -0.12 | -0.11 | -0.07 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
Revenue per share | 0.38 | 0.4 | 0.25 | 0.23 | 0.25 | |
Net income per share | 0.02 | 0.03 | 0.01 | 0.01 | 0.01 | |
Operating cash flow per share | 0.02 | 0.03 | 0.01 | 0.01 | 0.03 | |
Free cash flow per share | 0.01 | 0 | 0 | -0.02 | 0.02 | |
Cash per share | 0.58 | 0.32 | 0.17 | 0.23 | 0.18 | |
Book value per share | 0.81 | 0.84 | 0.53 | 0.6 | 0.63 | |
Tangible book value per share | 0.25 | 0.27 | 0.19 | 0.27 | 0.3 | |
Share holders equity per share | 0.81 | 0.84 | 0.53 | 0.6 | 0.63 | |
Interest debt per share | 0.92 | 0.88 | 0.5 | 0.53 | 0.49 | |
Market cap | 6.62B | 7.34B | 12.85B | 16.66B | 15.13B | |
Enterprise value | 7.25B | 8.43B | 13.88B | 17.63B | 16.1B | |
P/E ratio | 33.67 | 29.67 | 74.05 | 193.08 | 106.78 | |
Price to sales ratio | 8.71 | 9.12 | 15.56 | 21.41 | 18.27 | |
POCF ratio | 134.68 | 118.69 | 296.19 | 772.31 | 173.85 | |
PFCF ratio | 365.18 | 1.23K | -3.77K | -302.24 | 206.31 | |
P/B Ratio | 4.13 | 4.41 | 7.46 | 8.3 | 7.23 | |
PTB ratio | 4.13 | 4.41 | 7.46 | 8.3 | 7.23 | |
EV to sales | 9.54 | 10.47 | 16.8 | 22.65 | 19.44 | |
Enterprise value over EBITDA | 61.33 | 175.23 | 96.94 | 304.79 | 213.96 | |
EV to operating cash flow | 147.42 | 136.27 | 319.81 | 817.06 | 185.01 | |
EV to free cash flow | 399.73 | 1.42K | -4.07K | -319.75 | 219.55 | |
Earnings yield | 0.01 | 0.01 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 1.11 | 1.04 | 0.92 | 0.87 | 0.78 | |
Debt to assets | 0.29 | 0.31 | 0.28 | 0.3 | 0.28 | |
Net debt to EBITDA | 5.3 | 22.6 | 7.16 | 16.69 | 12.9 | |
Current ratio | 0.66 | 0.58 | 0.54 | 0.58 | 0.7 | |
Interest coverage | 1.36 | 1.07 | 1.39 | 0.98 | 1.48 | |
Income quality | 1 | 1 | 1 | 1 | 0 | |
Dividend Yield | 0.01 | 0.03 | 0 | 0 | 0 | |
Payout ratio | 0.78 | 3.27 | 0.45 | 1.05 | 0.58 | |
Sales general and administrative to revenue | -0.09 | 0.34 | -0.26 | 0.17 | -0.02 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.19 | 0.21 | 0.2 | 0.2 | 0.19 | |
Capex to operating cash flow | -0.63 | -0.9 | -1.08 | -3.56 | -0.16 | |
Capex to revenue | -0.04 | -0.07 | -0.06 | -0.1 | -0.02 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.67 | 0.77 | 0.4 | 0.3 | 0.39 | |
ROIC | 0.02 | 0.01 | 0.02 | 0.01 | 0.01 | |
Return on tangible assets | 0.01 | 0.01 | 0.01 | 0 | 0.01 | |
Graham Net | -1.27 | -1.19 | -0.75 | -0.65 | -0.65 | |
Working capital | -1.22B | -1.26B | -1.53B | -1.4B | -865.3M | |
Tangible asset value | 490.48M | 534.92M | 615.68M | 901.59M | 992.35M | |
Net current asset value | -2.1B | -2.03B | -2.08B | -1.82B | -1.73B | |
Invested capital | 1.11 | 1.04 | 0.92 | 0.87 | 0.78 | |
Average receivables | 864.55M | 911.92M | 988.2M | 1.03B | 1.1B | |
Average payables | 1.02B | 1.02B | 1.1B | 1.16B | 1.19B | |
Average inventory | 179.92M | 176.53M | 172.16M | 166.93M | 165.27M | |
Days sales outstanding | 106.94 | 102.86 | 115.06 | 115.67 | 130.51 | |
Days payables outstanding | 177.84 | 160.49 | 208.33 | 190.97 | 206.41 | |
Days of inventory on hand | 30.52 | 28.05 | 29.5 | 28.02 | 27.05 | |
Receivables turnover | 0.84 | 0.87 | 0.78 | 0.78 | 0.69 | |
Payables turnover | 0.51 | 0.56 | 0.43 | 0.47 | 0.44 | |
Inventory turnover | 2.95 | 3.21 | 3.05 | 3.21 | 3.33 | |
ROE | 0.03 | 0.04 | 0.03 | 0.01 | 0.02 | |
Capex per share | -0.02 | -0.03 | -0.01 | -0.02 | 0 |
002219.SZ Frequently Asked Questions
What is Hengkang Medical Group Co.,Ltd stock symbol ?
Hengkang Medical Group Co.,Ltd is a CN stock and trading under the symbol 002219.SZ
What is Hengkang Medical Group Co.,Ltd stock quote today ?
Hengkang Medical Group Co.,Ltd stock price is $3.48 today.
Is Hengkang Medical Group Co.,Ltd stock public?
Yes, Hengkang Medical Group Co.,Ltd is a publicly traded company.